UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 581

Sortiert nach

Radioimmunotherapy of human tumours

Nature reviews. Cancer, 2015-06, Vol.15 (6), p.347

2015

Link zum Volltext

Verfügbarkeit prüfen

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma

PloS one, 2013-12, Vol.8 (12), p.e82742

2013

Link zum Volltext

Verfügbarkeit prüfen

Whither Radioimmunotherapy: To Be or Not To Be?

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (9), p.2191-2196

2017

Link zum Volltext

Verfügbarkeit prüfen

A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells

Cell, 2014-06, Vol.157 (7), p.1644-1656

2014

Link zum Volltext

Verfügbarkeit prüfen

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

PloS one, 2018-10, Vol.13 (10), p.e0205135-e0205135

2018

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

ACS applied materials & interfaces, 2015-04, Vol.7 (12), p.6674-6682

2015

Link zum Volltext

Verfügbarkeit prüfen

Advances in the treatment of hematologic malignancies using immunoconjugates

Blood, 2014-04, Vol.123 (15), p.2293-2301

2014

Link zum Volltext

Verfügbarkeit prüfen

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Blood, 2012-04, Vol.119 (17), p.3940-3950

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

Journal of clinical oncology, 2013-05, Vol.31 (13), p.1662-1668

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3467-3474

2015

Link zum Volltext

Verfügbarkeit prüfen

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

The Lancet. Haematology, 2019-05, Vol.6 (5), p.e254-e265

2019

Link zum Volltext

Verfügbarkeit prüfen

Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides

Molecular pharmaceutics, 2017-05, Vol.14 (5), p.1450-1459

2017

Link zum Volltext

Verfügbarkeit prüfen

Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic Malignancies

Journal of Nuclear Medicine, 2020-09, Vol.61 (9), p.1300-1306

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models

PloS one, 2015-03, Vol.10 (3), p.e0120561

2015

Link zum Volltext

Verfügbarkeit prüfen

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

Journal of clinical oncology, 2018-03, Vol.36 (7), p.697-703

2018

Link zum Volltext

Verfügbarkeit prüfen

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8447-8452

2005

Link zum Volltext

Verfügbarkeit prüfen

A multicentre study of primary breast diffuse large B‐cell lymphoma in the rituximab era

British journal of haematology, 2014-05, Vol.165 (3), p.358-363

2014

Link zum Volltext

Verfügbarkeit prüfen

Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane

The Journal of immunology (1950), 2008-05, Vol.180 (10), p.7028-7038

2008

Link zum Volltext

Verfügbarkeit prüfen

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Blood, 2008-09, Vol.112 (6), p.2261-2271

2008

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy

British journal of haematology, 2015-10, Vol.171 (1), p.13-28

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016

Journal of clinical oncology, 2013-01, Vol.31 (3), p.314

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4143-4149

2006

Link zum Volltext

Verfügbarkeit prüfen

Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4132-4139

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 581

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(458)
Mit Volltextzugriff
(530)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(239)
Science & Technology
(238)
Life Sciences & Biomedicine
(228)
Female
(130)
Male
(104)
Biological And Medical Sciences
(102)
Medical Sciences
(100)
Oncology
(97)
Middle Aged
(96)
Adult
(87)
Animals
(83)
Hematology
(83)
Aged
(70)
Mice
(63)
Radioimmunotherapy
(63)
Antibodies, Monoclonal - Therapeutic Use
(56)
Hematologic And Hematopoietic Diseases
(48)
Treatment Outcome
(48)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(46)
Pharmacology. Drug Treatments
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Radioimmunotherapy of human tumours

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma

Whither Radioimmunotherapy: To Be or Not To Be?

Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

Advances in the treatment of hematologic malignancies using immunoconjugates

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides

Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic Malignancies

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

A multicentre study of primary breast diffuse large B‐cell lymphoma in the rituximab era

Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis

Suchergebnisse filtern